Journal for ImmunoTherapy of Cancer (Sep 2021)

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy

Hsin-Yu Liu,
Christophe Pedros,
Kok-Fai Kong,
Ann J Canonigo-Balancio,
Wen Xue,
Amnon Altman

Affiliations

Hsin-Yu Liu: La Jolla Institute for Immunology, La Jolla, California, USA
Christophe Pedros: La Jolla Institute for Immunology, La Jolla, California, USA
Kok-Fai Kong: La Jolla Institute for Immunology, La Jolla, California, USA
Ann J Canonigo-Balancio: La Jolla Institute for Immunology, La Jolla, California, USA
Wen Xue: University of Massachusetts Medical School, Worcester, Massachusetts, USA
Amnon Altman: La Jolla Institute for Immunology, La Jolla, California, USA

DOI: https://doi.org/10.1136/jitc-2021-002792
Journal volume & issue: Vol. 9, no. 9

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal